Aortic regurgitation - Revision history

Chris.Rishel: Added to infobox

2022-08-09T02:30:12Z

Added to infobox

← Older revision		Revision as of 19:30, 8 August 2022
Line 1:		Line 1:
	{{Infobox comorbidity		{{Infobox comorbidity
	\| other_names =		\| other_names = Aortic insufficiency
	\| anesthetic_relevance =		\| anesthetic_relevance = High
	\| specialty =		\| anesthetic_management =
			\| specialty = Cardiology
	\| signs_symptoms =		\| signs_symptoms =
	\| diagnosis =		\| diagnosis = [[Echocardiogram]]
	\| treatment =		\| treatment =
	\| image =		\| image =

Chris.Rishel at 01:03, 22 February 2022

2022-02-22T01:03:32Z

← Older revision		Revision as of 18:03, 21 February 2022
Line 75:		Line 75:

	[[Category:Comorbidities]]		[[Category:Comorbidities]]
			<references />
			[[Category:Cardiovascular disorders]]
			[[Category:Valvular heart disease]]

Oliviamsutton at 11:42, 5 December 2021

2021-12-05T11:42:07Z

← Older revision		Revision as of 04:42, 5 December 2021
Line 10:		Line 10:
	}}		}}

	~~Provide~~ a ~~brief summary~~ of ~~this comorbidity here~~.		Aortic regurgitation (AR) or insufficiency (AI) may be acute or chronic, and anesthetic goals may change as a result. These lesions are often a result of connective tissue disease or bicuspid AV, which predisposes patients to developing aortic aneurysms and dissection leading to aortic root dilation that disrupts the normal AV architecture, causing the valve cusps and leaflets to separate, resulting in AR.

	== Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> ==		== Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> ==
Line 17:		Line 17:

	* Increased risk of perioperative cardiovascular decompensation<ref>{{Citation\|title=Copyright\|date=2008\|url=http://dx.doi.org/10.1016/b978-1-4160-3998-3.50002-5\|work=Stoelting's Anesthesia and Co-Existing Disease\|pages=iv\|publisher=Elsevier\|access-date=2021-12-03}}</ref>		* Increased risk of perioperative cardiovascular decompensation<ref>{{Citation\|title=Copyright\|date=2008\|url=http://dx.doi.org/10.1016/b978-1-4160-3998-3.50002-5\|work=Stoelting's Anesthesia and Co-Existing Disease\|pages=iv\|publisher=Elsevier\|access-date=2021-12-03}}</ref>
			* Patient may have underlying connective tissue disease (Marfan, Ehlers-Danlos), bicuspid aortic valve, or inflammatory diseases of the aorta.

	=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===		=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===
Line 22:		Line 23:
	* Hemodynamic goals are to maintain forward flow and decrease regurgitant volume		* Hemodynamic goals are to maintain forward flow and decrease regurgitant volume
	** Preload: normal-high to augment CO		** Preload: normal-high to augment CO
	** Afterload: low-normal to promote forward flow		** Afterload: low-normal to promote forward flow, reducing aortic diastolic pressure0
	** Rate: high-normal		** Rate: high-normal (80s) to reduce time in diastole for regurgitation to occur
	** Rhythm: sinus (rate more important)		** Rhythm: sinus (rate more important)
	** Contractility: high-normal		** Contractility: high-normal
			* Hypotension should not be treated with pure vasoconstrictors, as arterial vasoconstriction will increase afterload and increase the regurgitant fraction.
			* Avoid medications such as phenylephrine which cause increased afterload and reflex bradycardia both of which contribute to increased AR.
			* Hypotension should be treated with augmentation of heart rate, preload and contractility.

	=== Postoperative management<!-- Describe how this comorbidity may influence postoperative management. --> ===		=== Postoperative management<!-- Describe how this comorbidity may influence postoperative management. --> ===

	== Related surgical procedures<!-- List and briefly describe any procedures which may be performed specifically to treat this comorbidity or its sequelae. If none, this section may be removed. --> ==		== Related surgical procedures<!-- List and briefly describe any procedures which may be performed specifically to treat this comorbidity or its sequelae. If none, this section may be removed. --> ==
			[[Aortic valve repair or replacement]]

	== Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. --> ==		== Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. --> ==
Line 41:		Line 46:

	== Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> ==		== Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> ==

			* Dyspnea on exertion
			* orthopnea
			* PND
			* Palpitations
			* Angina
			* Cyanosis in acute cases

	== Diagnosis<!-- Describe how this comorbidity is diagnosed. --> ==		== Diagnosis<!-- Describe how this comorbidity is diagnosed. --> ==

Oliviamsutton at 15:11, 3 December 2021

2021-12-03T15:11:39Z

← Older revision		Revision as of 08:11, 3 December 2021
Line 16:		Line 16:
	=== Preoperative optimization<!-- Describe how this comorbidity may influence preoperative evaluation and optimization of patients. --> ===		=== Preoperative optimization<!-- Describe how this comorbidity may influence preoperative evaluation and optimization of patients. --> ===

	* Increased risk of perioperative cardiovascular decompensation		* Increased risk of perioperative cardiovascular decompensation<ref>{{Citation\|title=Copyright\|date=2008\|url=http://dx.doi.org/10.1016/b978-1-4160-3998-3.50002-5\|work=Stoelting's Anesthesia and Co-Existing Disease\|pages=iv\|publisher=Elsevier\|access-date=2021-12-03}}</ref>

	=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===		=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===
Line 38:		Line 38:
	** RV failure > pulmonary HTN		** RV failure > pulmonary HTN
	* In acute AI, sudden increase in LV volume can induce cardiogenic shock and pulmonary edema		* In acute AI, sudden increase in LV volume can induce cardiogenic shock and pulmonary edema
			** Sudden AI that does not allow time for compensatory LV dilation can result in acute pulmonary congestion

	== Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> ==		== Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> ==
Line 48:		Line 49:

	* Diuretics, anticoagulants		* Diuretics, anticoagulants
			* Immediate management of acute AI involves afterload reduction (nitroprusside) & augmentation of contractility & rate (dobutamine)

	=== Surgery<!-- Describe surgical procedures used to treat this comorbidity. --> ===		=== Surgery<!-- Describe surgical procedures used to treat this comorbidity. --> ===

			* Severe acute AI may require emergency AV repair/replacement
			* Note that intra-aortic balloon pump is '''contraindicated'''

	=== Prognosis<!-- Describe the prognosis of this comorbidity --> ===		=== Prognosis<!-- Describe the prognosis of this comorbidity --> ===

Oliviamsutton at 15:06, 3 December 2021

2021-12-03T15:06:08Z

← Older revision		Revision as of 08:06, 3 December 2021
Line 15:		Line 15:

	=== Preoperative optimization<!-- Describe how this comorbidity may influence preoperative evaluation and optimization of patients. --> ===		=== Preoperative optimization<!-- Describe how this comorbidity may influence preoperative evaluation and optimization of patients. --> ===

			* Increased risk of perioperative cardiovascular decompensation

	=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===		=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===

			* Hemodynamic goals are to maintain forward flow and decrease regurgitant volume
			** Preload: normal-high to augment CO
			** Afterload: low-normal to promote forward flow
			** Rate: high-normal
			** Rhythm: sinus (rate more important)
			** Contractility: high-normal

	=== Postoperative management<!-- Describe how this comorbidity may influence postoperative management. --> ===		=== Postoperative management<!-- Describe how this comorbidity may influence postoperative management. --> ===
Line 23:		Line 32:

	== Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. --> ==		== Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. --> ==

			* Hemodynamic sequelae of AI:
			** LA distension > Volume overload > Subendothelial ischemia
			** CHF > pulmonary edema
			** RV failure > pulmonary HTN
			* In acute AI, sudden increase in LV volume can induce cardiogenic shock and pulmonary edema

	== Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> ==		== Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> ==
Line 31:		Line 46:

	=== Medication<!-- Describe medications used to manage this comorbidity. --> ===		=== Medication<!-- Describe medications used to manage this comorbidity. --> ===

			* Diuretics, anticoagulants

	=== Surgery<!-- Describe surgical procedures used to treat this comorbidity. --> ===		=== Surgery<!-- Describe surgical procedures used to treat this comorbidity. --> ===

Oliviamsutton: Created page with "{{Infobox comorbidity | other_names = | anesthetic_relevance = | specialty = | signs_symptoms = | diagnosis = | treatment = | image = | caption = }} Provide a brief s..."

2021-12-03T15:01:52Z

Created page with "{{Infobox comorbidity | other_names = | anesthetic_relevance = | specialty = | signs_symptoms = | diagnosis = | treatment = | image = | caption = }} Provide a brief s..."

New page

{{Infobox comorbidity
| other_names =
| anesthetic_relevance =
| specialty =
| signs_symptoms =
| diagnosis =
| treatment =
| image =
| caption =
}}

Provide a brief summary of this comorbidity here.

== Anesthetic implications ==

=== Preoperative optimization ===

=== Intraoperative management ===

=== Postoperative management ===

== Related surgical procedures ==

== Pathophysiology ==

== Signs and symptoms ==

== Diagnosis ==

== Treatment ==

=== Medication ===

=== Surgery ===

=== Prognosis ===

== Epidemiology ==

== References ==

[[Category:Comorbidities]]